Neil Vasan, MD, PhD, is a physician-scientist in the Department of Medicine and the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. The Vasan Lab uses functional genomics to understand how oncoproteins regulate breast cancer cell signaling, growth, and therapeutic response.

Dr. Vasan received his AB/AM from Harvard University and MD/PhD from Yale University School of Medicine, and completed clinical training in internal medicine at Massachusetts General Hospital and in medical oncology at Memorial Sloan Kettering Cancer Center. As a postdoctoral fellow, he identified double PIK3CA mutations as an oncogenic alteration, which has gone from bench to bedside as a cancer genomic biomarker. His research awards include the NIH K08, Susan G. Komen Career Catalyst Research grant, American Association for Cancer Research (AACR) NextGen Star, and American Society for Clinical Investigation (ASCI) Young Physician-Scientist Award. Dr. Vasan is an active clinical oncologist treating patients with breast cancer and serves as a standing member of the Oncologic Drugs Advisory Committee (ODAC) for the FDA.